Reference health

Sleep Disturbance in Supportive Care of Cancer: A Review

https://doi.org/10.1089/jpm.2006.9.437
CiteStamped reference-health badge
2 of 116 checkable references need attention · checked 2026-07-22

At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.

12 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

References needing attention

does not resolve to a known work10.1210/jc.84.8.2603
does not resolve to a known work10.1001/jama.262.11.1479
The 114 checked references that resolve
resolves10.1046/j.1365-2869.2003.00355.x
Daytime activity and risk factors for late‐life insomnia
resolves10.1016/0885-3924(90)90015-C
Hospitalized advanced cancer patients: A profile
resolves10.1016/0022-3999(84)90003-5
Cancer-related pain—I. Prevalence in an outpatient setting as a function of stage of disease and type of cancer
resolves10.1002/1097-0142(19821101)50:9<1913::AID-CNCR2820500944>3.0.CO;2-R
The prevalence and severity of pain in cancer
resolves10.1002/1097-0142(19890201)63:3<593::AID-CNCR2820630332>3.0.CO;2-5
Pain experience and pain management among hospitalized cancer patients. A clinical study
resolves10.1200/JCO.2002.08.549
Anxiety Disorders in Cancer Patients: Their Nature, Associations, and Relation to Quality of Life
resolves10.1053/meta.2002.33357
Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime
resolves10.1016/S0889-1591(02)00065-X
Sleep in host defense
resolves10.1002/cncr.11382
Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism?
resolves10.1001/archpsyc.58.5.445
Cytokine-Associated Emotional and Cognitive Disturbances in Humans
resolves10.1097/00006842-200207000-00010
Fatigue and Proinflammatory Cytokine Activity in Breast Cancer Survivors
resolves10.1016/S0889-1591(02)00079-X
Immune-to-central nervous system communication and its role in modulating pain and cognition: Implications for cancer and cancer treatment
resolves10.1016/S0360-3016(01)01657-1
Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer
resolves10.1111/j.1749-6632.2000.tb05413.x
Experimental Immunomodulation, Sleep, and Sleepiness in Humans
resolves10.1053/smrv.1999.0068
REVIEW ARTICLE: Sleep and cytokine–immune functions in medical, psychiatric and primary sleep disorders
resolves10.1111/j.1749-6632.2002.tb04240.x
Psychoneuroimmunology
resolves10.1046/j.1524-4741.2002.08606.x
Sleep Disturbances in Women With Metastatic Breast Cancer
resolves10.1016/0885-3924(95)00056-5
Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer
resolves10.1002/pon.525
Nonpharmacologic group treatment of insomnia: a preliminary study with cancer survivors
resolves10.1002/(SICI)1097-0347(199705)19:3<169::AID-HED1>3.0.CO;2-0
Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue
resolves10.1200/JCO.1998.16.4.1380
Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer.
resolves10.1007/BF00435383
Symptom prevalence, characteristics and distress in a cancer population
resolves10.1093/sleep/24.5.583
Prevalence, Clinical Characteristics, and Risk Factors for Insomnia in the Context of Breast Cancer
resolves10.1097/00002820-199904000-00006
Sleep alterations in cancer patients
resolves10.1200/JCO.1995.13.11.2737
Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy.
resolves10.1080/00223980.1983.9915403
Sleep Patterns in Patients with Cancer and Patients with Cardiac Disease
resolves10.1016/0885-3924(91)90027-2
Symptoms of pancreatic cancer
resolves10.1177/014107689408700705
Assessment of the Impact of Cancer on Work, Recreation, Home Management and Sleep Using a General Health Status Measure
resolves10.1200/JCO.2001.19.3.895
Insomnia in the Context of Cancer: A Review of a Neglected Problem
resolves10.1016/S0277-9536(01)00043-0
Sleep disturbance in cancer patients
resolves10.1016/j.jpainsymman.2003.09.010
The prevalence, key causes and management of insomnia in palliative care patients
resolves10.1007/s00520-004-0623-4
Sleep disorders in advanced cancer patients: prevalence and factors associated
resolves10.1200/JCO.1993.11.5.997
Assessment of sleep in patients with lung cancer and breast cancer.
resolves10.1016/S0885-3924(02)00500-6
Sleep and Quality of Life in Breast Cancer Patients
resolves10.1891/0889-7182.14.4.275
Insomnia, Fatigue, Anxiety, Depression, and Quality of Life of Cancer Patients Undergoing Chemotherapy
resolves10.1016/0277-9536(94)00249-S
Relationship of caregiver reactions and depression to cancer patients' symptoms, functional states and depression—A longitudinal view
resolves10.1002/pon.860
Empirical validation of the Insomnia Severity Index in cancer patients
resolves10.1016/S0895-4356(97)00238-2
Psychotropic Medication Consumption Patterns in the UK General Population
resolves10.4088/JCP.v63n0912
Use of Psychotropic Medication in the General Population of France, Germany, Italy, and the United Kingdom
resolves10.4088/PCC.v03n0303
Medications for the Treatment of Sleep Disorders
resolves10.1016/j.jpsychires.2003.10.003
Chronic benzodiazepine usage and withdrawal in insomnia patients
resolves10.1056/NEJM199701303360506
Management of Insomnia
resolves10.2165/00003088-200443040-00002
Comparative Pharmacokinetics and Pharmacodynamics of Short-Acting Hypnosedatives
resolves10.1016/j.euroneuro.2003.09.007
Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study
resolves10.1177/104990910302000512
Toward evidence-based prescribing at end of life: A comparative review of temazepam and zolpidem for the treatment of insomnia
resolves10.1093/sleep/26.7.793
Sustained Efficacy of Eszopiclone Over 6 Months of Nightly Treatment: Results of a Randomized, Double-Blind, Placebo-Controlled Study in Adults with Chronic Insomnia
resolves10.1016/j.mcna.2004.01.008
Identification and management of insomnia
resolves10.1016/j.phrs.2004.05.002
Methadone—metabolism, pharmacokinetics and interactions
resolves10.1002/hup.630
The effects of methadone and its role in fatalities
resolves10.4088/JCP.v62n0609
Doxepin in the Treatment of Primary Insomnia
resolves10.1097/00004714-200204000-00006
Acute Efficacy of Fluoxetine Versus Sertraline and Paroxetine in Major Depressive Disorder Including Effects of Baseline Insomnia
resolves10.4088/JCP.v60n0204
Paroxetine in the Treatment of Primary Insomnia
resolves10.1016/S0304-3959(99)00154-2
Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action
resolves10.1016/S0022-3999(98)00079-8
Are prescribed medications effective in the treatment of insomnia complaints?
resolves10.1007/BF02247467
Clinical and polysomnographic effects of trazodone CR in chronic insomnia associated with dysthymia
resolves10.1046/j.1440-1819.1999.00532.x
Effect of trazodone in a single dose before bedtime for sleep disorders accompanied by a depressive state: Dose‐finding study with no concomitant use of hypnotic agent
resolves10.1016/S0278-5846(01)00262-7
Insomnia in depression: Differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone
resolves10.1007/s005200000215
Mirtazapine may be useful in treating nausea and insomnia of cancer chemotherapy
resolves10.1016/S0885-3924(02)00381-0
An Open-Label, Crossover Trial of Mirtazapine (15 and 30 mg) in Cancer Patients with Pain and Other Distressing Symptoms
resolves10.1177/104990910101800111
Mirtazepine: Heir apparent to amitriptyline?
resolves10.1016/S0885-3924(02)00645-0
Mirtazapine for Pruritus
resolves10.1586/14737140.2.4.365
Management of symptons associated with advanced cancer: olanzapine and mirtazapine
resolves10.1002/(SICI)1099-1166(199910)14:10<851::AID-GPS33>3.0.CO;2-L
The use of non-prescription sleep products in the elderly
resolves10.1176/appi.ajgp.11.2.205
Sedative-Hypnotic Use of Diphenhydramine in a Rural, Older Adult, Community-Based Cohort: Effects on Cognition
resolves10.1111/j.1469-8749.1994.tb11818.x
THE TREATMENT OF SLEEP DISORDERS WITH MELATONIN
resolves10.1093/sleep/18.7.598
Melatonin Replacement Therapy of Elderly Insomniacs
resolves10.1046/j.1365-2826.2003.00989.x
Role of Melatonin in the Regulation of Human Circadian Rhythms and Sleep
resolves10.1159/000227533
Increased Survival Time in Brain Glioblastomas by a Radioneuroendocrine Strategy with Radiotherapy plus Melatonin Compared to Radiotherapy Alone
resolves10.1007/BF00432503
Effect of valerian on human sleep
resolves10.1016/0091-3057(82)90264-7
Aqueous extract of valerian root (Valeriana officinalis L.) improves sleep quality in man
resolves10.1016/0091-3057(89)90082-8
Double blind study of a Valerian preparation
resolves10.1016/S0278-5846(01)00305-0
Can valerian improve the sleep of insomniacs after benzodiazepine withdrawal?
resolves10.1200/JCO.2004.08.182
Herbal Remedies in the United States: Potential Adverse Interactions With Anticancer Agents
resolves10.1002/ptr.1422
Kava treatment in patients with anxiety
resolves10.5694/j.1326-5377.2004.tb05875.x
Fatal fulminant hepatic failure induced by a natural therapy containing kava
resolves10.1016/j.jep.2004.04.009
Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.)
resolves10.1177/1534735404265003
Safety and Efficacy of Herbal Sedatives in Cancer Care
resolves10.1176/appi.psy.43.3.175
An Open Trial of Olanzapine for the Treatment of Delirium in Hospitalized Cancer Patients
resolves10.1177/0891988702250533
Treatment of Delirium in Older Adults with Quetiapine
resolves10.1002/hup.559
A pilot trial of quetiapine for the treatment of patients with delirium
resolves10.4088/PCC.v02n0103
Treatment of Delirium With Quetiapine
resolves10.1007/BF01788847
Usage of haloperidol for delirium in cancer patients
resolves10.1176/ajp.153.2.231
A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients
resolves10.1016/S0033-3182(04)70170-X
A Double-Blind Trial of Risperidone and Haloperidol for the Treatment of Delirium
resolves10.1191/026921601678576185
Communication Capacity Scale and Agitation Distress Scale to measure the severity of delirium in terminally ill cancer patients: a validation study
resolves10.1176/ajp.140.8.1048
Delirium in terminally ill cancer patients
resolves10.1016/S0749-0690(05)70061-6
DELIRIUM IN THE TERMINALLY ILL
resolves10.1176/ajp.151.8.1172
Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy
resolves10.1001/jama.281.11.991
Behavioral and Pharmacological Therapies for Late-Life Insomnia
resolves10.1037/0022-006X.63.1.79
Identifying effective psychological treatments for insomnia: A meta-analysis.
resolves10.1093/sleep/22.8.1128
Practice Parameters for the Nonpharmacologic Treatment of Chronic Insomnia
resolves10.1001/jama.285.14.1856
Cognitive Behavioral Therapy for Treatment of Chronic Primary Insomnia
resolves10.1016/S0005-7967(01)00004-3
Insomniacs' reported use of CBT components and relationship to long-term clinical outcome
resolves10.1053/smrv.2001.0246
Use of sleep hygiene in the treatment of insomnia
resolves10.1177/089198870001300103
An Actigraphic Comparison of Sleep Restriction and Sleep Hygiene Treatments for Insomnia in Older Adults
resolves10.1016/S1087-0792(97)90012-5
Hyperarousal and insomnia
resolves10.1016/S0005-7967(99)00091-1
Relaxation therapy for insomnia: nighttime and day time effects
resolves10.1037/0022-006X.69.2.227
Relaxation and sleep compression for late-life insomnia: A placebo-controlled trial.
resolves10.1177/01454455930174005
Multifactor Behavioral Treatment of Chronic Sleep-Onset Insomnia Using Stimulus Control and the Relaxation Response
resolves10.1007/BF01001167
Biofeedback and progressive relaxation treatment of sleep-onset insomnia
resolves10.1901/jaba.1979.12-37
RELAXATION TREATMENT OF PSEUDOINSOMNIA AND IDIOPATHIC INSOMNIA: AN ELECTROENCEPHALOGRAPHIC EVALUATION
resolves10.1111/j.2044-8341.1982.tb01494.x
Progressive relaxation, EMG biofeedback and biofeedback placebo in the treatment of sleep‐onset insomnia
resolves10.1037/0882-7974.8.1.103
Relaxation for insomnia and hypnotic medication use in older women.
resolves10.1016/S0005-7967(01)00012-2
The management of unwanted pre-sleep thoughts in insomnia: distraction with imagery versus general distraction
resolves10.1037/0022-006X.55.2.260
Stimulus control and imagery training in treating sleep-maintenance insomnia.
resolves10.1037/0882-7974.3.3.258
Treatment of sleep-maintenance insomnia in older adults: Sleep period reduction, sleep education, and modified stimulus control.
resolves10.1037/0882-7974.10.1.54
Sleep compression and sleep education for older insomniacs: Self-help versus therapist guidance.
resolves10.1016/0005-7967(83)90211-5
The treatment of sleep-maintenance insomnia with stimulus-control techniques
resolves10.1007/s00520-004-0594-5
Sleep management training for cancer patients with insomnia
resolves10.1016/0005-7916(83)90056-3
Treatment of insomnia in cancer patients using muscle relaxation training
resolves10.1016/0005-7916(86)90008-X
The treatment of severe insomnia in a cancer patient
resolves10.1093/oxfordjournals.annonc.a010766
Rapid discontinuation of hypnotics in terminal cancer patients: A prospective study
resolves10.1093/sleep/26.2.177
A Primary Care “Friendly” Cognitive Behavioral Insomnia Therapy
The 12 references without a DOI — listed, not checked
no DOI — not checkedp_21
no DOI — not checkedp_27
no DOI — not checkedp_43
no DOI — not checkedp_45
no DOI — not checkedp_48
no DOI — not checkedp_61
no DOI — not checkedp_66
no DOI — not checkedp_68
no DOI — not checkedp_109
no DOI — not checkedp_143
no DOI — not checkedp_147
no DOI — not checkedp_148
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1089/jpm.2006.9.437"><img src="https://citestamp.com/citestamped/10.1089/jpm.2006.9.437/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1089/jpm.2006.9.437/badge.svg)](https://citestamp.com/citestamped/10.1089/jpm.2006.9.437)